Valmet Chosen by Lotte E&C to Deliver Automation to Gwangyang Biomass Plant in Korea

Valmet will supply a Valmet DNA distributed control system (DCS) to Gwangyang Green Energy Corporation’s biomass power plant under construction in Southwest Province in South Korea. The order was placed by Lotte Engineering and Construction Co., Ltd (Lotte E&C), which is the engineering, procurement, and construction (EPC) contractor for the plant.

Visualization of the Gwangyang biomass plant in South Korea. Image Credit: Valmet

The order was included in Valmet’s orders received of the second quarter 2023. Its value will not be disclosed. The deliveries will start in June 2024, and the start-up is scheduled for March 2025.

This is the first time Lotte E&C has chosen Valmet’s automation technology for its power plant projects. Valmet’s experience and advanced control system offer enhanced operational efficiency and sustainable energy production, as well as improved reliability operating the biomass plant.

’’Valmet is a proven supplier for the biomass plant control system globally. We are looking forward to a successful project completion and future project collaboration,’’ says Changhyun Jung, Manager, Power Green Energy Department, Plant Business Division, Lotte E&C.

“This is a continuous order in the biomass power plant business in Korea, following the Dangjin biomass power plant. This is meaningful for Valmet’s automation systems, which have proven their high quality and flexible operation over the past year and have diversified Valmet’s business portfolio in Korea. We are ready to further collaborate with our customers in Korea,” says Emilia Torttila-Miettinen, President, Automation Systems business line, Valmet.

Technical Information of the Delivery

Valmet’s delivery consists of a DNA automation system, a safety control system, and an information management system to control the boiler and balance of plant (BOP) of the new biomass power plant, covering engineering, design, documents, commissioning and supervision works.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.